A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis

Gut

Volumn 45, Issue 1, 1999, Pages 97-104

  Uhl, W ^a   Buchler M W ^a,d   Malfertheiner, P ^b   Beger, H G ^c   Adler, G ^c   Gaus, W ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute pancreatitis; Octreotide; Randomised controlled multicentre trial; Somatostatin

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS SECRETION; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032966293     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.1.97     Document Type: Article

References (59)

1. 1 Bradley EL III, A clinically based classification system of acute pancreatitis. Arch Surg 1993;128:586-90.
2. 2 Karimgani I, Porter KA, Langevin ER, et al. Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992; 103:1636-40.
3. 3 Beger HG, Büchler M, Bittner R, et al. Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 1988;75:207-21.
4. 4 Sarr MH, Nagorney DM, Much P, et al. Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy debridement and delayed primary wound closure over drains. Br J Surg 1991;78:576-81.
5. 5 Rattner DW, Legermate DA, Lee MJ, et al. Surgical debridement of symptomatic pancreatic necrosis is beneficial irrespective of infection. Am J Surg 1992;163:105-10.
6. 6 Steinberg WM, Schlesselmann SE. Treatment of acute pancreatitis: comparison of animal and human studies. Gastroenterology 1987;93:1420-7.
7. 7 Leese T, Holliday M, Watkins M, et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis, Ann R Coll Surg Engl 1991;73:207-14.
8. 5 Büchler M, Malfertheiner P, Uhl W, et al. Gabexate mesilate in human acute pancreatitis. Gastroenterology 1993;104: 1165-70.
9. 9 Chiari H. Ueber die Selbstverdauung des menschlichen Pankreas. Z Heilk 1896;17:69-96.
10. 10 Adler G, Kern HF, Scheele GA, Experimental models and concepts of acute pancreatitis. In: Go VLW, et al, eds. The exocrine pancreas. New York: Raven Press, 1986:407-21.
11. 11 Limberg K, Kommerell, B. Treatment of acute pancreatitis with somatostatin. N Engl J Med 1980;79:284.
12. 12 Usadel KH, Uberla KK, Leuschner U. Treatment of acute pancreatitis with somatostatin: results of the multicentre double-blind trial (APTS). Dig Dis Sci 1985;30:A992
13. 13 Schöndube F, Klempa I, Baca I, et al. Nekrotisierende Pankreatitis - ein Beitrag zur stadiengerechten operativen Therapie. ACA 1987;19:354-5.
14. 14 Zuniga J, Garcia L, Ortiz J, et al. Estudio de la efficacia del tratamiento con somatostatina en pancreatitis agudes grave. Proc de las XIV Jornadas Hispano-Francesas De Gastroenterolog. Burgas: 10th Reunion de la Associationn Castelleno del Aparta Digestiva, October, 1987:39-40.
15. 15 Sanchez D, Sanchez A, Zucdu JR, et al. Pancreatitis aguda. Estudio clinico y terrapeutico valoracion de la somatostatin. Ann Med Intern (Madrid) 1983;(suppl 3):A40.
16. 16 Choi TK, Mok F, Zhan WH, et al. Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut 1989;30:223-7.
17. 17 D'Amico D, Favia C, Biasiato R, et al. The use of somatostatin in acute pancreatitis: results of a multicentre trial. Hepatogastroenterology 1990;37:92-8.
18. 18 Carballo F, Dominguez-Munoz JE, Fernandez-Calvet L, et al. Is somatostatin useful in the treatment of acute pancreatitis? A meta-analysis. Digestion 1991;49:A12-13.
19. 19 Niederau C, Niederau M, Lüthen R, et al. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology 1990;99:1120-7.
20. 20 Regan PT, Malagelada JR, Go VLW, et al. A prospective study of the antisecretory effects of cimetidine and glucagoh in human acute pancreatitis, Mayo Clin Proc 1981;56:499-503.
21. 21 Dominguez-Munoz JE, Pieramico O, Büchler M, et al. Exocrine pancreatic function in the early phase of human acute pancreatitis. Scand J Gastroenterol 1995;30:186-91.
22. 22 Binder M, Uhl W, Friess H, et al. Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. Digestion 1994;55:20-3.
23. 23 Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-9.
24. 24 Beger HG, Bittner R, Büchler M, et al. Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986;90:74-9.
25. 25 Büchler M, Malfertheiner P, Schädlich H, et al. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989;97:1521-6.
26. 26 Beger HG, Bittner R, Block S, et al. Bacterial contamination of pancreatic necrosis. A prospective study. Gastroenterology 1986;91:453-8.
27. 27 Degertekin H, Ertan A, Akdamar K, et al. Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice. Peptides 1985;6:1245-7.
28. 28 Schlarmann DE, Beinfeld MC, Andrus C, et al. Effects of somatostatin on acute canine experimental pancreatitis, Int J Pancreatol 1987;2:247-55.
29. 29 Murayama KM, Drew FB, Joehl RJ. Does somatostatin analogue prevent experimental acute pancreatitis? Arch Surg 1990;125:1570-2.
30. 30 Metrakos P, Rosenberg L, Duguid WP, et al. Prophylactic sandostatin potentiates acute pancreatitis. Surg Forum 1990;41:160-1.
31. 31 Zhu ZH, Holt S, El-Lbishi MS, et al. A somatostatin analoque is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas 1991;6:609-13.
32. 32 Lankisch PG, Koop H, Winckler K, et al. Somatostatin therapy of acute pancreatitis. Gut 1977;18:713-16.
33. 33 Schwedes U, Althoff PH, Klempa I, et al. Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res 1979;11:655-61.
34. 34 Mann NS, Mauch MJ, Barnett R. Intraductal somatostatin protects against experimentally induced pancreatitis. Gastroenterology 1980;78:1217.
35. 35 Baxter JN, Jenkins SA, Day DW, et al. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis. Br J Surg 1985;72:382-5.
36. 36 Baxter JN, Jenkins SA, Day DW, et al. Effects of a somatostatin analogue on hepatic and splenic reticuloendothelial function in rats, Br J Surg 1985;75:1005-8.
37. 37 Augelli NV, Hussain SM, McKain MM, et al. Effect of SMS 201-995 (a long-acting somatostatin analogue) on bile-induced acute hemorrhagic pancreatitis in the dog. Arch Surg 1989;55:389-91.
38. 38 Bauer W, Briner U, Doepfner WW, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133-40.
39. 39 Kemmer TP, Malferteiner P, Büchler M, et al. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995). Aliment Pharmacol Ther 1992;6:41-50.
40. 40 Gjorup I, Roikjaer O, Andersen B, et al. A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. Surg Gynecol Obstet 1992;175:397-400.
41. 41 Luengo L, Vicente V, Gris F, et al. Influence of somatostatin in the evolution of acute pancreatitis - a prospective randomized study. Int J Pancreatol 1994;15:139-44.
42. 42 Beechey-Newmann N, Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Dig Dis Sci 1993;38: 644-7.
43. 43 O'Hair DP, Hoffmann RG, Schroeder H, et al. Octreotide in the treatment of acute pancreatitis: a prospective, randomized trial [abstract], Gastroenterology 1993;104:A 326.
44. 44 Paran H, Neufeld D, Mayo A, et al. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg 1995;181: 121-4.
45. 45 Fiedler F, Jauernig G, Keim V, et al. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure. Intensive Care Med 1996;22:909-15.
46. 46 McKay C, Baxter J, Imrie C. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol 1997;21:13-19.
47. 47 Isenmann R, Büchler M, Uhl W, et al. Pancreatic necrosis is an early finding in severe acute pancreatitis. Pancreas 1993; 8:358-61.
48. 48 Uhl W, Isenmann R, Curti G, et al. Influence of the etiology on the course and outcome of acute pancreatitis. Pancreas 1996;13:335-43.
49. 49 Ranson JHC, Balthazar E, Caccavale R, et al. Computed tomography and the prediction of pancreatic abscess in acute pancreatitis. Ann Surg 1985;201:656-65.
50. 50 Bordas JM, Toledo V, Mondelo F, et al. Prevention of pancreatic reactions hy bolus somatostatin administration in patients undergoing endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy, Hormone Res 1988;29:106-8.
51. 51 Büchler M, Friess H, Klempa I, et al. The role of somatostatin analogue octreoride in the prevention of postoperative complications following pancreatic resection. The results of a multicenter controlled trial. Am J Surg 1992;163:125-30.
52. 52 Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994;81:265-9.
53. 53 Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-3.
54. 54 Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 1995;117:26-31.
55. 55 Stratta RJ, Taylor RJ, Lowell JA, et al. Selective use of somatostatin in vascularized pancreas transplantation. Am J Surg 1993;166:598-605.
56. 56 Büchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992;103:1902-8.
57. 57 Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:180-3.
58. 58 Luiten EJT, Hop WCJ, Lanje JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995;222:57-65.
59. 59 Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995;346:663-7.